- Premacure to Initiate Phase II Trial for IPLEX(TM) in Retinopathy of Prematurity -
RICHMOND, Va. and UPPSALA, Sweden, Sept. 23 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq CM: INSM), a developer of follow-on biologics (FOBs) and biopharmaceuticals, and Premacure AB, a biopharmaceutical company dedicated to the development of diagnosis and prevention of complications in neonates due to premature birth, today noted the presentation of clinical study results demonstrating that Insmed's IPLEX(TM) product, a complex of recombinant human insulin-like growth factor (rhIGF-I) and its predominant binding protein IGFBP-3 (rhIGFBP-3), increased serum IGF-I levels into the normal range in significantly premature infants. Premacure is developing IPLEX(TM) as a potential treatment for Retinopathy of Prematurity (ROP) via a Material Transfer Agreement with Insmed.
These most recent study results were reported today at the European Society for Pediatric Endocrinology 47th annual meeting, Istanbul, Turkey, by Investigators from the Harvard Medical School, Boston MA, and the University of Gothenburg, The Karolinska Institute, Stockholm, Lund University, Sweden, in a poster entitled "Pharmacokinetic study of recombinant human (rh) insulin-like growth factor/rh IGFBP-3 complex administered to very low birth weight infants."
"The possibility of preventing ROP and other complications of
prematurity by replicating the in utero environment after infants are born
prematurely and lose the factors normally provided by the maternal
environment is very exciting," said Lois Smith, Professor of Ophthalmology,
Harvard Medical School, Children's Hospital Boston. "This work showing that
it is now possible to raise the serum level of IGF-1 and IGFBP-3 to normal
in utero levels in these fragile infants with IGF-1 / IGFBP-3 deficiency is
a critical step in the development of interventions that prevent ROP. Since
we have shown that low IGF-1 is associated with ROP, this of
|SOURCE Insmed Inc.; Premacure AB|
Copyright©2008 PR Newswire.
All rights reserved